AAAAAA

   
Results: 1-18 |
Results: 18

Authors: Sitnitskaya, Y Rochford, G Rigaud, M Essajee, S Pollack, H Krasinski, K Borkowsky, W
Citation: Y. Sitnitskaya et al., Prevalence of the T215Y mutation in human immunodeficiency virus type 1-infected pregnant women in a New York cohort, 1995-1999, CLIN INF D, 33(1), 2001, pp. E3-E7

Authors: Cunningham, CK Wara, DW Kang, MH Fenton, T Hawkins, E McNamara, J Mofenson, L Duliege, AM Francis, D McFarland, EJ Borkowsky, W
Citation: Ck. Cunningham et al., Safety of 2 recombinant human immunodeficiency virus type 1 (HIV-1) envelope vaccines in neonates born to HIV-1-Infected women, CLIN INF D, 32(5), 2001, pp. 801-807

Authors: Bush, L Malecki, J Wiersma, S Cahill, K Fried, R Grossman, M Borkowsky, W
Citation: L. Bush et al., Investigation of anthrax associated with intentional exposure and interim public health guidelines, October 2001 (Reprinted from MMWR, vol 50, pg 889, 2001), J AM MED A, 286(17), 2001, pp. 2086-2088

Authors: McFarland, EJ Borkowsky, W Fenton, T Wara, D McNamara, J Samson, P Kang, MH Mofenson, L Cunningham, C Duliege, AM Sinangil, F Spector, SA Jimenez, E Bryson, Y Burchett, S Frenkel, LM Yogev, R Gigliotti, F Luzuriaga, K Livingston, RA
Citation: Ej. Mcfarland et al., Human immunodeficiency virus type 1 (HIV-1) gp120-specific antibodies in neonates receiving an HIV-1 recombinant gp120 vaccine, J INFEC DIS, 184(10), 2001, pp. 1331-1335

Authors: Essajee, SM Pollack, H Rochford, G Oransky, I Krasinski, K Borkowsky, W
Citation: Sm. Essajee et al., Early changes in quasispecies repertoire in HIV-infected infants: Correlation with disease progression, AIDS RES H, 16(18), 2000, pp. 1949-1957

Authors: Nachman, SA Stanley, K Yogev, R Pelton, S Wiznia, A Lee, S Mofenson, L Fiscus, S Rathore, M Jimenez, E Borkowsky, W Pitt, J Smith, ME Wells, B McIntosh, K
Citation: Sa. Nachman et al., Nucleoside analogs plus ritonavir in stable antiretroviral therapy-experienced HIV-infected children - A randomized controlled trial, J AM MED A, 283(4), 2000, pp. 492-498

Authors: Spiegel, HML Ogg, GS DeFalcon, E Sheehy, ME Monard, S Haslett, PAJ Gillespie, G Donahoe, SM Pollack, H Borkowsky, W McMichael, AJ Nixon, DF
Citation: Hml. Spiegel et al., Human immunodeficiency virus type 1-and cytomegalovirus-specific cytotoxicT lymphocytes can persist at high frequency for prolonged periods in the absence of circulating peripheral CD4(+) T cells, J VIROLOGY, 74(2), 2000, pp. 1018-1022

Authors: Frenkel, LM Capparelli, EV Dankner, WM Xu, J Smith, IL Ballow, A Culnane, M Read, JS Thompson, M Mohan, KM Shaver, A Robinson, CA Stempien, MJ Burchett, SK Melvin, AJ Borkowsky, W Petru, A Kovacs, A Yogev, R Goldsmith, J McFarland, EJ Spector, SA
Citation: Lm. Frenkel et al., Oral ganciclovir in children: Pharmacokinetics, safety, tolerance, and antiviral effects, J INFEC DIS, 182(6), 2000, pp. 1616-1624

Authors: Spiegel, HML Chandwani, R Sheehy, ME Dobroszycki, J Fennelly, G Wiznia, A Radding, J Rigaud, M Pollack, H Borkowsky, W Rosenberg, M Nixon, DF
Citation: Hml. Spiegel et al., The impact of early initiation of highly active antiretroviral therapy on the human immunodeficiency virus type 1-specific CD8 T cell response in children, J INFEC DIS, 182(1), 2000, pp. 88-95

Authors: Borkowsky, W Stanley, K Douglas, SD Lee, S Wiznia, A Pelton, S Yogev, R McIntosh, K Nachman, S
Citation: W. Borkowsky et al., Immunologic response to combination nucleoside analogue plus protease inhibitor therapy in stable antiretroviral therapy-experienced human immunodeficiency virus-infected children, J INFEC DIS, 182(1), 2000, pp. 96-103

Authors: King, JC Borkowsky, W Mahidhara, N Madore, D Shapiro, ED Rutstein, RM Tan, TQ Farley, JJ Dankner, WM Nachman, S Simoes, E Flynn, PM Clemens, J Hamilton, RG
Citation: Jc. King et al., Group-specific antibody levels surrounding invasive pneumococcal illness in children infected with human immunodeficiency virus, J INFEC DIS, 181(5), 2000, pp. 1817-1821

Authors: Borkowsky, W Wara, D Fenton, T McNamara, J Kang, MH Mofenson, L McFarland, E Cunningham, C Duliege, AM Francis, D Bryson, Y Burchett, S Spector, SA Frenkel, LM Starr, S Van Dyke, R Jimenez, E
Citation: W. Borkowsky et al., Lymphoproliferative responses to recombinant HIV-1 envelope antigens in neonates and infants receiving gp120 vaccines, J INFEC DIS, 181(3), 2000, pp. 890-896

Authors: Essajee, SM Kim, M Gonzalez, C Rigaud, M Kaul, A Chandwani, S Hoover, W Lawrence, R Spiegel, H Pollack, H Krasinski, K Borkowsky, W
Citation: Sm. Essajee et al., Immunologic and virologic responses to HAART in severely immunocompromisedHIV-1-infected children, AIDS, 13(18), 1999, pp. 2523-2532

Authors: Kostrikis, LG Neumann, AU Thomson, B Korber, BT McHardy, P Karanicolas, R Deutsch, L Huang, YX Lew, JF McIntosh, K Pollack, H Borkowsky, W Spiegel, HML Palumbo, P Oleske, J Bardeguez, A Luzuriaga, K Sullivan, J Wolinsky, SM Koup, RA Ho, DD Moore, JP
Citation: Lg. Kostrikis et al., A polymorphism in the regulatory region of the CC-chemokine receptor 5 gene influences perinatal transmission of human immunodeficiency virus type 1 to African-American infants, J VIROLOGY, 73(12), 1999, pp. 10264-10271

Authors: Luzuriaga, K Wu, HL McManus, M Britto, P Borkowsky, W Burchett, S Smith, B Mofenson, L Sullivan, JL
Citation: K. Luzuriaga et al., Dynamics of human immunodeficiency virus type 1 replication in vertically infected infants, J VIROLOGY, 73(1), 1999, pp. 362-367

Authors: Spiegel, HML DeFalcon, E Ogg, GS Larsson, M Beadle, TJ Tao, P McMichael, AJ Bhardwaj, N O'Callaghan, C Cox, WI Krasinski, K Pollack, H Borkowsky, W Nixon, DE
Citation: Hml. Spiegel et al., Changes in frequency of HIV-1-specific cytotoxic T cell precursors and circulating effectors after combination antiretroviral therapy in children, J INFEC DIS, 180(2), 1999, pp. 359-368

Authors: Zhang, LQ Lewin, SR Markowitz, M Lin, HH Skulsky, E Karanicolas, R He, YX Jin, X Tuttleton, S Vesanen, M Spiegel, H Kost, R van Lunzen, J Stellbrink, HJ Wolinsky, S Borkowsky, W Palumbo, P Kostrikis, LG Ho, DD
Citation: Lq. Zhang et al., Measuring recent thymic emigrants in blood of normal and HIV-1-infected individuals before and after effective therapy, J EXP MED, 190(5), 1999, pp. 725-732

Authors: Lambert, JS McNamara, J Katz, SL Fenton, T Kang, MH VanCott, TC Livingston, R Hawkins, E Moye, J Borkowsky, W Johnson, D Yogev, S Duliege, AM Francis, L Gershon, A Wara, D Martin, N Levin, F McSherry, F Smith, G
Citation: Js. Lambert et al., Safety and immunogenicity of HIV recombinant envelope vaccines in HIV-infected infants and children, J ACQ IMM D, 19(5), 1998, pp. 451-461
Risultati: 1-18 |